AT
Andrew Tsai Jefferies Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
11
Avg Return
Past Year
Past Year
2.2%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
76.9%
Neutral
23.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Real Estate
Healthcare
Biotechnology
Drug Manufacturers - General
Real Estate
Real Estate Services
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Hold
Downgraded
| $56 |
4%
upside
| 1 | – |
–
| 9 Oct ‘25 3 days ago |
|
|
|
Buy
Initiated
| $190 |
30%
upside
| 1 | +6.5% |
0
%
| 25 Sep ‘25 17 days ago |
|
|
|
Buy
Maintained
| $35 |
58%
upside
| 3 | -23% |
0
%
| 24 Jul ‘25 2 months ago |
|
|
|
Buy
Initiated
| $30 |
1%
downside
| 1 | +144% |
0
%
| 18 Jul ‘25 2 months ago |
|
|
|
Buy
Initiated
| $70 |
26%
upside
| 1 | +19% |
0
%
| 14 Jul ‘25 3 months ago |
|
|
|
Buy
Maintained
| $110 | – | 1 | +23% |
0
%
| 11 Jun ‘25 4 months ago |
|
|
|
Hold
Downgraded
| $2.50 |
27%
downside
| 2 | -80% |
0
%
| 28 May ‘25 4 months ago |
|
|
|
Buy
Initiated
| $200 |
64%
upside
| 1 | +23% |
0
%
| 7 Apr ‘25 6 months ago |
|
|
|
Overweight
Maintained
| $27 |
53%
upside
| 1 | -24% |
0
%
| 19 Mar ‘25 6 months ago |
|
|
|
Hold
Downgraded
| $0.5000 |
9%
downside
| 1 | – |
–
| 25 Oct ‘24 11 months ago |
|